Awakn Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 15, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	3	3	8	40	-
Market Cap Growth	-38.86%	-60.60%	-79.55%	-	-
Enterprise Value	2	3	8	37	-
Last Close Price	0.07	0.09	0.25	1.58	-
PS Ratio	67.78	49.22	-	215.09	-
PB Ratio	-2.54	-2.81	-218.72	16.80	-
P/TBV Ratio	-	-	13.75	20.87	-
EV/Sales Ratio	60.39	42.87	-	197.71	-
Debt / Equity Ratio	-	-	-46.15	0.60	0.28
Asset Turnover	0.07	0.04	-	0.06	-
Quick Ratio	0.26	0.21	0.28	0.94	1.59
Current Ratio	0.29	0.24	0.40	1.14	1.97
Return on Equity (ROE)	-	-	-333.47%	-944.54%	-
Return on Assets (ROA)	-171.98%	-99.41%	-58.54%	-158.96%	-
Return on Capital (ROIC)	-	-685.77%	-93.21%	-225.51%	-
Earnings Yield	-57.20%	-116.55%	-84.04%	-31.41%	-
FCF Yield	-	-55.38%	-67.68%	-20.26%	-
Buyback Yield / Dilution	-43.03%	-15.34%	-14.75%	-73.91%	-

Updated Dec 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.